Endowment Managers' Compensation Reported

Harvard Management Company has issued its annual report on the compensation of its highest-earning investment professionals...

Harvard Management Company (HMC) has issued its annual report on the compensation of its most highly paid in-house investment professionals. The news, often the subject of close scrutiny, comes at a particularly sensitive time.

The managers' compensation is heavily performance-based: their base salaries are supplemented by substantial bonuses only if they exceed market rates of return in the asset classes for which they are responsible--and, further, sustain that return over time (if performance subsequently lags, bonuses earned but not yet paid out can be "clawed back"). During fiscal year 2008, which ended last June 30, HMC achieved an 8.6 percent return on endowment assets--much better than the 13.1 percent decline in the Standard & Poor's index of large U.S. stocks and even ahead of the 7.1 percent return on the broadest bond-market proxy. The aggregate return for the fiscal year exceeded market returns of 6.9 percent on HMC's benchmarks for its portfolio overall, yielding an extra "value-added" margin of investment return, worth $600 million to the endowment. During the stellar fiscal 2007 year, HMC's aggregate return was 23 percent: 5.8 percentage points better than market benchmarks, representing extra endowment returns of $1.7 billion.

Those halcyon days--which in fact drive much of this year's bonus awards--are of course overshadowed in memory by the recent sharp decline in the value of Harvard's endowment, and those of all known peer institutions, reflecting the rout in financial markets worldwide since last summer. (Whatever the returns for the current fiscal year turn out to be, they may, of course, be relatively better or worse than the performance of the relevant market benchmarks for HMC's asset classes; that, in turn, will figure into compensation awards for future years.)

According to the news release, these were the five highest-paid employees (figures include salaries, bonuses, and benefits):

Stephen Blyth, $6.4 million, Managing Director--International Fixed Income

Marc Seidner, $6.3 million, Managing Director--Domestic Fixed Income

Stanley Zuzic, $4.9 million, Senior Vice President--Domestic Equities

Steven Alperin, $4.4 million. Managing Director--Emerging Market Equities

Andrew Wiltshire,$3.9 million, Managing Director--Natural Resources

In addition, Mohamed El-Erian, former president and CEO, was paid $921,000. He announced his intention to resign and to return to his previous employer in California, in September 2007, and departed that December. 

For past coverage of HMC compensation, including some explanation of the performance-related bonus system, see also here and here.

 

You might also like

From Jellyfish to Digital Hearts

How Harvard researchers are helping to build a virtual model of the human heart

Harvard Football: Harvard 31, Columbia 14

The Crimson stay unbeaten with a workmanlike win over the Lions.

Harvard Faculty of Arts and Sciences Faces a $350 Million Deficit

At a faculty meeting, Dean Hopi Hoekstra advocates for long-term, structural solutions.

Most popular

Harvard Divinity School Sets New Priorities

After two years of turmoil, Dean Marla Frederick describes a more pluralistic future for the institution’s culture and curriculum.

Portraying Larry Summers

Celebrating the twenty-seventh president—and assessing his legacy

Yale Chief Will Lead Harvard Police Department

Anthony Campbell will take up his new post in January.

Explore More From Current Issue

A person walks across a street lined with historic buildings and a clock tower in the background.

Harvard In the News

A legal victory against Trump, hazing in the Harvard-Radcliffe Orchestra, and kicking off a Crimson football season with style

Two small cast iron pans with berry-topped desserts, dusted with powdered sugar, alongside lemon slices.

Shopping for New England-made gifts this Holiday Season

Ways to support regional artists, designers, and manufacturers 

Professor David Liu smiles while sitting at a desk with colorful lanterns and a figurine in the background.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.